Biohub secures $2B from US government, Google, Meta for AI biology initiative

Summary

The US government, alongside Google and Meta Platforms, is investing $1.8 billion into the nonprofit Biohub to create open datasets for training AI models in biological research. This initiative, known as the Virtual Biology Initiative, aims to measure cellular responses to numerous conditions and expedite drug development timelines. Notably, Meta and its partners, including Google DeepMind and Isomorphic Labs, are contributing $300 million, while the Department of Energy plans to invest over $500 million over five years. Biohub's head of science, Alex Rives, highlighted that the first dataset is expected within a year, with accurate predictive models anticipated in five years, advancing efforts already being pursued by other AI labs like Anthropic and OpenAI.

Tokens

$META$GOOGL

Analysis

Biohub: Biohub is a nonprofit research organization established as a philanthropic venture by Mark Zuckerberg and Priscilla Chan. It is leading the Virtual Biology Initiative to measure cellular responses and create comprehensive datasets that enable AI models for biological research and drug discovery. Google: Google, as part of Alphabet, develops advanced AI technologies with applications in science and research. It is participating in the Biohub-led Virtual Biology Initiative via its DeepMind lab to help generate and utilize biology datasets for training predictive AI models. Alex Rives: Alex Rives is the head of science at Biohub, responsible for guiding its research initiatives. He has outlined the project's approach to data generation, predictive modeling, and policies for sharing results with both commercial partners and the public. US Government: The US Government encompasses federal agencies responsible for advancing scientific research and innovation across multiple domains. In this news, it is partnering with Biohub and technology companies to support the creation of large-scale open datasets for AI applications in biology through coordinated funding and standardization efforts. Meta Platforms: Meta Platforms is a technology company focused on AI development and social platforms. It is collaborating with Biohub, Google DeepMind, and Isomorphic Labs on the initiative to build AI-ready biological datasets as part of broader efforts to advance scientific research. Google DeepMind: Google DeepMind is an AI research organization specializing in developing systems for complex scientific problems. It is jointly investing with Meta and Isomorphic Labs to support Biohub's effort in producing biology datasets for AI training. Isomorphic Labs: Isomorphic Labs is a startup applying AI to accelerate drug discovery and biological research. It is a key commercial participant in the joint investment with Meta and Google DeepMind to fund Biohub's dataset-building initiative. Mark Zuckerberg: Mark Zuckerberg serves as CEO of Meta Platforms and co-founder of Biohub alongside his wife Dr. Priscilla Chan. Through Biohub, his philanthropic work is driving the funding and direction of the AI biology data project aimed at accelerating scientific discovery. Data Access Model: Biohub structures its projects to provide commercial funders an initial embargo period before releasing datasets publicly as open scientific resources. Research Acceleration: The Virtual Biology Initiative focuses on techniques like spatial transcriptomics to capture cell responses in ways that support faster development of predictive biological models. Complementary Initiatives: Other leading AI labs such as Anthropic and OpenAI are also actively pursuing biology data generation and related programs to enhance model training capabilities.

Categories

techaipoliticsai_agentsmachine_learning
View Original Tweet